Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples